Showing results (1011-1020 of 1,035) with videos related to
Sort By:
Pageof 104
The New England Journal of Medicine|November 18, 2024
Routine Spironolactone in Acute Myocardial InfarctionSanjit S Jolly, Marc-André d'Entremont, Bertram Pitt, et al.Resuscitation|February 27, 2026
Relationship between Cortical Electrical Responsiveness and Changes in Regional Cerebral Oxygenation (rSO2) and Return of Spontaneous Circulation in Prolonged Cardiac Arrest: A Multi-Center Observational StudyElise L Huppert, Emma Roellke, Deepti Anbarasan, et al.Science Signaling|January 30, 2024
Pannexin-3 stabilizes the transcription factor Bcl6 in a channel-independent manner to protect against vascular oxidative stressAbigail G Wolpe, Melissa A Luse, Christopher Baryiames, et al.JACC. Cardiooncology|January 6, 2021
Allogeneic Mesenchymal Cell Therapy in Anthracycline-Induced Cardiomyopathy Heart Failure Patients: The CCTRN SENECA TrialRoberto Bolli, Emerson C Perin, James T Willerson, et al.Resuscitation|July 9, 2023
AWAreness during REsuscitation - II: A multi-center study of consciousness and awareness in cardiac arrestSam Parnia, Tara Keshavarz Shirazi, Jignesh Patel, et al.Molecular Plant-Microbe Interactions : MPMI|June 21, 2012
Genome sequencing and mapping reveal loss of heterozygosity as a mechanism for rapid adaptation in the vegetable pathogen Phytophthora capsiciKurt H Lamour, Joann Mudge, Daniel Gobena, et al.Nature Communications|June 24, 2026
hexABC seeking the physical code of DNAFederica Battistini, Miłosz Wieczór, Adam Hospital, et al.European Journal of Heart Failure|April 3, 2021
A Phase II study of autologous mesenchymal stromal cells and c-kit positive cardiac cells, alone or in combination, in patients with ischaemic heart failure: the CCTRN CONCERT-HF trialRoberto Bolli, Raul D Mitrani, Joshua M Hare, et al.NPJ Vaccines|November 20, 2024
Preclinical characterization of the Omicron XBB.1.5-adapted BNT162b2 COVID-19 vaccineKayvon Modjarrad, Ye Che, Wei Chen, et al.JAMA|March 27, 2012
Effect of transendocardial delivery of autologous bone marrow mononuclear cells on functional capacity, left ventricular function, and perfusion in chronic heart failure: the FOCUS-CCTRN trialEmerson C Perin, James T Willerson, Carl J Pepine, et al.Pageof 104